Equity Capital Markets

Company · CIK 1169245

PhaseBio Pharmaceuticals Inc

CIK1169245 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressPA
Listedno ticker on SEC record today
First annual or quarterly report2018-11-29

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-235735
ShelfEffective
 2019-12-272021-11-125
333-230783
Registered companyFinal prospectus
 2019-04-092019-04-123
333-227474
IPOFinal prospectus
 2018-09-212018-10-195

Filings

15
FiledFilingRegistrationAccession
2021-11-12424B5Shelf takedown 333-2357350001193125-21-328078
2021-03-19424B5Shelf takedown 333-2357350001193125-21-087468
2021-03-17424B5Shelf takedown 333-2357350001193125-21-084200
2020-01-08EFFECTDeclared effective 333-2357359999999995-20-000039
2019-12-27S-3Shelf registered 333-2357350001193125-19-324990
2019-04-12424B4Final prospectus 333-2307830001193125-19-105228
2019-04-11EFFECTDeclared effective 333-2307839999999995-19-000684
2019-04-09S-1Registration filed 333-2307830001193125-19-101668
2019-03-29DRSDraft made public 377-025650000950123-19-002942
2018-10-19424B4Final prospectus 333-2274740001193125-18-302148
2018-10-17EFFECTDeclared effective 333-2274749999999995-18-002647
2018-10-15S-1/AAmendment 333-2274740001193125-18-298749
2018-10-05S-1/AAmendment 333-2274740001193125-18-294730
2018-09-21S-1Registration filed 333-2274740001193125-18-280007
2018-07-27DRSDraft made public 377-021910000950123-18-007059

All filings of this company · CSV